Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neuralgia 2Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain, Intractable 1Pain 1Neoplasms 1Lymphoma, Follicular 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × ziconotide × Clear all
NCT00996983 2023-03-24

ZIDON

National Cancer Institute, Naples

Phase 2 Unknown
16 enrolled

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT01373983 2014-12-30

ZicBol

University Hospital, Linkoeping

Phase 4 Completed
26 enrolled
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Neuralgia, Peripheral Nervous System Diseases, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡